The 2023 Shanghai International Biopharmaceutical Industry Week was successfully held in Shanghai on October 16~20 with the theme of "Shaping the Future, Enriching the Life." Adhering to the principle of "high-end, characterization, and globalization", the industry week aimed to set up industry benchmarks, through the innovative achievements and industry momentum contributed by the leading companies.

Innolake Biopharm（Hangzhou）Co., Ltd. was recognized on the list of "2023 China Biopharmaceutical Top 100". The true industry leaders must be pioneers in cutting-edge technologies and take the lead in industrial transformation. Innolake was recognized on the Top 100 list for its outstanding innovation strength, R&D efficiency and execution capabilities. As a rising force of innovative drug development, Innolake is committed to forging ahead on its unique innovation pathway.